Back to Screener

Healthcare

Cabaletta Bio, Inc.(CABA)

Live Price

Offline

$2.84

+0.00% today

Window Change

-24.87%

Window

May 29, 2026 โ†’ Jun 18, 2026

Market Cap
$400.00M
Revenue Growth
0.0%
EPS Growth
+29.9%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 15 bars ยท May 29, 2026 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Cabaletta Bio, Inc. (CABA) is a Healthcare stock with a market cap of $400.00M. The stock last traded around $2.84 and down 24.9% across the available one-year price window (May 29, 2026 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +29.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +29.9%, free cash flow -46.3% with operating margin 0.0% and ROIC -123.8%. Stock Foundry combines CABA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +7.6% peer median

Operating Margin

Below sector median

0.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 21, 2026, but the surprise data is still limited.

The setup is mixed rather than one-directional

Revenue is 0.0% and EPS is +29.9%, while operating margin sits near 0.0%.

Benchmark Edge

CABA vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CABA

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CABA Max Drawdown

-25.93%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CABA and SPY.

Calendar-year return history is still loading or unavailable.
CA

Company Overview

Cabaletta Bio, Inc.

Last Updated
May 7, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
3.8

Growth

Revenue
0.0%
EPS
+29.9%
Free Cash Flow
-46.3%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-121.7%
ROIC
-123.8%

Balance Sheet

Debt/Equity
0.24
Current Ratio
2.77

Earnings Reports

๐Ÿ“… Last reportedMay 21, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 21, 26
โ€”
Est -0.41
โ€”
โ€”
Est 1666.7B
โ€”
โ€”
Mar 23, 26
โœ“
-0.40
Est -0.45
+11.1%
โ€”
Est 833.3B
โ€”
โ€”
Nov 10, 25
โœ“
-0.44
Est -0.49
+10.2%
โ€”
Est โ€”
โ€”
โ€”
Aug 7, 25
โœ—
-0.73
Est -0.71
-2.8%
โ€”
Est 4166.7B
โ€”
โ€”
May 15, 25
โœ—
-0.71
Est -0.67
-6.0%
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 25
โ€”
-0.65
Est -0.65
0.0%
1638.0B
Est โ€”
โ€”
โ€”
Nov 14, 24
โœ—
-0.62
Est -0.59
-5.1%
โ€”
Est โ€”
โ€”
โ€”
Aug 8, 24
โœ—
-0.56
Est -0.55
-1.8%
โ€”
Est โ€”
โ€”
โ€”
May 15, 24
โœ—
-0.51
Est -0.48
-6.3%
โ€”
Est โ€”
โ€”
โ€”
Mar 21, 24
โœ—
-0.46
Est -0.39
-17.9%
4010.0B
Est โ€”
โ€”
โ€”
Nov 9, 23
โœ“
-0.37
Est -0.39
+5.1%
โ€”
Est โ€”
โ€”
โ€”
Aug 10, 23
โœ“
-0.37
Est -0.47
+21.3%
โ€”
Est โ€”
โ€”
โ€”
May 11, 23
โœ“
-0.45
Est -0.48
+6.3%
โ€”
Est โ€”
โ€”
โ€”
Mar 16, 23
โœ—
-0.52
Est -0.47
-10.6%
โ€”
Est โ€”
โ€”
โ€”
Nov 10, 22
โœ“
-0.39
Est -0.49
+20.4%
โ€”
Est โ€”
โ€”
โ€”
Aug 11, 22
โœ“
-0.45
Est -0.52
+13.5%
โ€”
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks